ArticleMolecular therapy : the journal of the American Society of Gene Therapy2010

Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.

Kazuhiko Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.